Debt-to-equity of REGENXBIO Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
REGENXBIO Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • REGENXBIO Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 127%, a 83% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

REGENXBIO Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 127% +57% +83% 30 Sep 2025
Q2 2025 96% +26% +37% 30 Jun 2025
Q1 2025 73% +2% +2.2% 31 Mar 2025
Q4 2024 68% -3% -3.8% 31 Dec 2024
Q3 2024 69% +4% +6% 30 Sep 2024
Q2 2024 70% +9% +14% 30 Jun 2024
Q1 2024 71% +14% +25% 31 Mar 2024
Q4 2023 71% +17% +31% 31 Dec 2023
Q3 2023 66% +15% +31% 30 Sep 2023
Q2 2023 61% +8% +16% 30 Jun 2023
Q1 2023 57% +1% +2.2% 31 Mar 2023
Q4 2022 54% -5% -8% 31 Dec 2022
Q3 2022 50% -19% -28% 30 Sep 2022
Q2 2022 53% -7% -12% 30 Jun 2022
Q1 2022 56% +8% +17% 31 Mar 2022
Q4 2021 59% +24% +71% 31 Dec 2021
Q3 2021 70% +54% +336% 30 Sep 2021
Q2 2021 60% +49% +464% 30 Jun 2021
Q1 2021 48% +39% +424% 31 Mar 2021
Q4 2020 34% +26% +319% 31 Dec 2020
Q3 2020 16% +9% +120% 30 Sep 2020
Q2 2020 11% +4% +72% 30 Jun 2020
Q1 2020 9% +3% +54% 31 Mar 2020
Q4 2019 8% +2% +43% 31 Dec 2019
Q3 2019 7% +2% +28% 30 Sep 2019
Q2 2019 6% -1% -8.3% 30 Jun 2019
Q1 2019 6% -1% -14% 31 Mar 2019
Q4 2018 6% -1% -15% 31 Dec 2018
Q3 2018 6% -1% -11% 30 Sep 2018
Q2 2018 7% 0% +1.8% 30 Jun 2018
Q1 2018 7% 0% +7.4% 31 Mar 2018
Q4 2017 7% +1% +17% 31 Dec 2017
Q3 2017 6% +2% +39% 30 Sep 2017
Q2 2017 7% +3% +111% 30 Jun 2017
Q1 2017 6% 31 Mar 2017
Q4 2016 6% 31 Dec 2016
Q3 2016 5% 30 Sep 2016
Q2 2016 3% 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.